Growth and expansion for Aptamer Group in 2022
As we come to the end of 2022 and our first year as a listed company, the year in review shows a clear theme of growth and expansion across…
As we come to the end of 2022 and our first year as a listed company, the year in review shows a clear theme of growth and expansion across…
04/02/2020 Biotechnology companies Aptamer Group and Valitacell Ltd have joined forces to develop a next-generation screening platform for drug development. Aptamer Group will be working alongside Valitacell…